“protagonist-therapeutics” Archives

in
Entry Author Date Location
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More 08/10/18 National
Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More 03/30/18 National
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
Protagonist Therapeutics Receives $90,000,000 New Round 08/11/16 San Francisco
Foresite Capital Keeps Late-Stage Healthcare Focus With $450M Third Fund 07/29/15 San Francisco
Ra Pharma Gets $58.5M in Crossover Cash to Target Rare Blood Disease 07/23/15 Boston
Protagonist Therapeutics Secures $40,000,000 Series C Funding Round 07/20/15 San Francisco
West Coast Biotech Roundup: Receptos, ProNAi, Protagonist & More 07/16/15 San Diego
Orphan Drug Maker Chiasma Raises $101.8M in IPO 07/16/15 Boston
Protagonist Nabs $40M, Eyes 1st Trial Of Oral Peptide In Gut Disease 07/16/15 San Francisco
Protagonist Therapeutics Secures $4,000,000 Series B Round 09/19/13 San Francisco
Johnson & Johnson’s New Innovation Center Part of Broader Initiative 06/07/13 San Francisco
Protagonist Therapeutics Secures $14,000,000 Series B Round 06/05/13 San Francisco
Protagonist Pulls in $14M, Led by J&J, For Peptide Pills 06/04/13 San Francisco
Protagonist Criss-Crosses Pacific, in Search of New Peptide Drugs 07/11/12 San Francisco
Vertex Drug Gets Speedy FDA Review, BSX Buys Atritech, Ironwood Strikes Another Deal, & More Boston-Area Life Sciences News 01/21/11 Boston
Ironwood, One of the Big Boys Now, Strikes Deal With Tiny Protagonist Therapeutics 01/18/11 Boston
Page 1 of 1